TriSalus Life Sciences, Inc. Common Stock (TLSI) is a publicly traded Healthcare sector company. As of May 21, 2026, TLSI trades at $3.27 with a market cap of $186.09M and a P/E ratio of -1.75. TLSI moved +2.70% today. Year to date, TLSI is -46.97%; over the trailing twelve months it is -39.66%. Its 52-week range spans $2.20 to $7.95. Analyst consensus is strong buy with an average price target of $8.80. Rallies surfaces TLSI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
TLSI financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TLSI recently traded at $3.27. Market cap is $186.09M. P/E ratio is -1.75. Revenue is $45.15M.
| Metric | Value |
|---|---|
| Price | $3.27 |
| Market Cap | $186.09M |
| P/E Ratio | -1.75 |
| EPS | $-1.84 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.95 |
| 52-Week Low | $2.20 |
| Volume | 359 |
| Avg Volume | 0 |
| Revenue (TTM) | $45.15M |
| Net Income | $-39.23M |
| Gross Margin | 84.57% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $45.15M | $-39.23M | $-1.84 |
| 2024 | $29.43M | $-30.05M | $-1.31 |
| 2023 | $18.51M | $-59.04M | $-6.73 |
5 analysts cover TLSI: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.80.